AHC · ASX

Austco Healthcare Ltd (ASX:AHC)

AU$0.26

 -0.0025 (-0.962%)
ASX:Live
06/11/2024 03:59:56 PM
HALO Price Momentum HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

AHC Overview

AHC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About AHC

Telephone

Address

Description

Austco Healthcare Ltd. engages in the development, manufacture, and supply of hardware relating to healthcare and electronic communications systems. It operates through the following geographical segments: Australia/New Zealand, Asia, Europe, and North America. The company was founded by Robert Edward Grey in 2004 and is headquartered in Port Melbourne, Australia.

AHC Price Chart

Key Stats

Market Cap

AU$92.84M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

100%

Ex Dividend Date (est.)

02-Mar-23

Market Data

52 weeks range

Low 0.17 - 0.26

Trade Value (12mth)

AU$10,763.00

1 week

1.96%

1 month

-1.89%

YTD

30.29%

1 year

44.77%

All time high

0.79

Key Fundamentals

EPS 3 yr Growth

94.20%

EBITDA Margin

13.90%

Operating Cashflow

$11m

Free Cash Flow Return

32.10%

ROIC

20.00%

Interest Coverage

54.40

Quick Ratio

1.80

Other Data

Shares on Issue (Fully Dilluted)

311m

HALO Sector

Next Company Report Date

27-Aug-25

Ex Dividend Date (est.)

02-Mar-23

Next Dividend Pay Date (est.)

05-Apr-23

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AHC Announcements

Latest Announcements

Date Announcements

31 October 24

Chair's Address to Shareholders

×

Chair's Address to Shareholders

31 October 24

CEO's Address to Shareholders

×

CEO's Address to Shareholders

31 October 24

Results of Meeting

×

Results of Meeting

31 October 24

Notification regarding unquoted securities - AHC

×

Notification regarding unquoted securities - AHC

31 October 24

Change of Director's Interest Notice - Astles

×

Change of Director's Interest Notice - Astles

30 October 24

Austco Healthcare Q1FY25 Trading Update

×

Austco Healthcare Q1FY25 Trading Update

22 October 24

Change of Director's Interest Notice - Astles

×

Change of Director's Interest Notice - Astles

14 October 24

Change in substantial shareholding from AEF

×

Change in substantial shareholding from AEF

01 October 24

Notification regarding unquoted securities - AHC

×

Notification regarding unquoted securities - AHC

01 October 24

Issue of Performance Rights

×

Issue of Performance Rights

30 September 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

25 September 24

Change of Director's Interest Notice - Burns

×

Change of Director's Interest Notice - Burns

23 September 24

Annual Report to shareholders

×

Annual Report to shareholders

19 September 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

19 September 24

Ceasing to be a substantial holder - Correction

×

Ceasing to be a substantial holder - Correction

12 September 24

Application for quotation of securities - AHC

×

Application for quotation of securities - AHC

12 September 24

Change of Director's Interest Notice - Astles

×

Change of Director's Interest Notice - Astles

11 September 24

Notification of cessation of securities - AHC

×

Notification of cessation of securities - AHC

09 September 24

Austco expands Jurong contract to A$5.5m with phase 2 win

×

Austco expands Jurong contract to A$5.5m with phase 2 win

05 September 24

Austco Healthcare Investor Presentation

×

Austco Healthcare Investor Presentation

29 August 24

Appendix 4E & FY24 Financial Statements

×

Appendix 4E & FY24 Financial Statements

29 August 24

Austco FY24 Results Media Release

×

Austco FY24 Results Media Release

29 August 24

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

11 July 24

Austco Healthcare Trading Update

×

Austco Healthcare Trading Update

08 July 24

Austco Healthcare awarded $5.0m contract

×

Austco Healthcare awarded $5.0m contract

AHC Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.01 0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.01 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -32.5 -3.7 198.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 0.01 0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 -0.00 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.7 3.9 87.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock 6.1 -1.6 17.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -41.5 -100.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 37 22 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.08 0.09 0.12 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.06 0.07 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock 16.2 4.8 -2.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 286 292 309 Lock Lock Lock
Basic m Lock Lock Lock Lock 286 290 304 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 36 42 58 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.8 17.0 38.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 5 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 6 7 12 Lock Lock Lock
     Growth % Lock Lock Lock Lock 18.0 15.6 81.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 16.1 15.9 20.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 84 84 79 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 4 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.3 2.7 130.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.5 8.4 13.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2 2 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1.8 -11.7 221.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.7 4.3 10.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 3 2 6 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2 2 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -32.0 -3.0 213.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.5 5.4 12.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 2 0 11 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 2 4 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -2 -11 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 -2 9 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 2 0 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -43.2 -93.0 7,865.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.0 0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 2 2 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 8 5 14 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 34 38 69 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -7 -4 -12 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 11 13 24 Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 25 44 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 24 25 46 Lock Lock Lock
     Growth % Lock Lock Lock Lock 18.1 6.8 81.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 6.8 6.0 10.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 10.1 9.0 15.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 9.2 7.3 16.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 10.7 9.3 20.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 9.0 1.3 32.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 65.9 51.8 54.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -1.9 -1.2 -1.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -28.8 -16.6 -26.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.6 2.4 2.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.7 1.5 1.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 27.9 15.7 33.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 18.5 2.5 66.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.8 4.0 4.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 4.2 3.5 4.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.1 2.4 2.5 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 18.8 19.9 16.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.0 1.1 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.0 1.1 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 7.3 4.3 9.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 7.7 4.8 8.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 11.4 -24.4 -25.2 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 6.8 6.0 10.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 1.5 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 10.1 9.0 15.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 63.1 77.6 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 6.4 7.0 15.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 86.9 103.6 85.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 75.7 91.6 85.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 162.6 195.2 171.2 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 55.3 74.5 70.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 107.3 120.7 100.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

02-Mar-23

DIV Yield

N/A

Franking Level

100%

DPSg

-100.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AHC Shortsell

Frequently Asked Questions

The current share price of Austco Healthcare Ltd (AHC:ASX) is AU$0.26.
The 52-week high share price for Austco Healthcare Ltd (AHC:ASX) is AU$0.26.
The 52-week low share price for Austco Healthcare Ltd (AHC:ASX)? is AU$0.17.
Austco Healthcare Ltd (AHC:ASX) does not pay a dividend.
The last dividend payment of Austco Healthcare Ltd (AHC:ASX) is AU$0.00.
Austco Healthcare Ltd (AHC:ASX) has a franking level of 100.0%.
Austco Healthcare Ltd (AHC:ASX) is classified in the Industrials.
The current P/E ratio for Austco Healthcare Ltd (AHC:ASX) is .